When Biotech Analysts Become Strategic, Some With 40% to 100% Implied Upside!
The NASDAQ and the S&P 500 have both overcome all odds and hit new all-time highs in 2025. One group...
Read moreDetailsLatest Post
Wall Street Firms Making Bold & Strategic Earnings Projections — On Their Rivals!!!
Earnings season is about to kick off, and while Oggonomics doesn't forecast earnings it certainly watches when Wall Street issues...
Read moreDetails
Three Massive Energy Plays for Strategic investors Looking for Growth & Income
It has been a difficult year in 2025 to invest in energy stocks. An expanded allowance for energy production and...
Read moreDetails
NIKE Emerges as the Next Great Strategic Blue Chip… Or Is It?
NIKE, Inc. (NYSE: NKE) is back! After losing more than half of its value since the end of 2021, NIKE...
Read moreDetails
Circle’s Strategic case: Wall Street Running in Circles Around First Analyst Ratings
Circle Internet Group (NYSE: CRCL) was a boost for the crypto sector and for the broader market of initial public...
Read moreDetailsPopular Post
-
What a Fully Depleted Social Security Fund REALLY Means for Your Retirement
-
Why ‘Underappreciated’ & ‘Mispriced’ Zeta Stock Could Rise 30%
-
Bull Market Conundrum: Buybacks Still Chasing All-Time Stock Market Highs
-
The U.S. Sovereign Wealth Fund That Could Be (and What It Could Have Been!)
-
Stocks Predicted to Rise 50% in 2026
Oggonomics delivers daily stock analysis, Wall Street analyst coverage, and no-nonsense market commentary for investors who think for themselves.
Learn more
